Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Other
Butyl Methoxydibenzoylmethane, commonly known as Avobenzone, is a critical organic sunscreen agent belonging to the dibenzoylmethane derivative class, primarily used for broad-spectrum UVA protection.
Name
Butyl Methoxydibenzoylmethane
Raw Name
BUTYL METHOXYDIBENZOYLMETHANE
Category
Other
Drug Count
14
Variant Count
14
Last Verified
February 17, 2026
About Butyl Methoxydibenzoylmethane
Butyl Methoxydibenzoylmethane, commonly known as Avobenzone, is a critical organic sunscreen agent belonging to the dibenzoylmethane derivative class, primarily used for broad-spectrum UVA protection.
Detailed information about Butyl Methoxydibenzoylmethane
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Butyl Methoxydibenzoylmethane.
Butyl Methoxydibenzoylmethane, more commonly recognized by its global trade name Avobenzone, is a synthetic organic compound that serves as a cornerstone in modern photoprotection (skin protection against light). It belongs to a specific class of drugs known as topical ultraviolet (UV) filters, specifically a dibenzoylmethane derivative. Unlike many other sunscreen agents that primarily target UVB rays (the rays responsible for immediate sunburn), Butyl Methoxydibenzoylmethane is unique because it provides comprehensive protection across the entire Ultraviolet A (UVA) spectrum, ranging from approximately 310 to 400 nanometers (nm). This includes both UVA-II (320–340 nm) and UVA-I (340–400 nm).
The Food and Drug Administration (FDA) first approved Butyl Methoxydibenzoylmethane for over-the-counter (OTC) use in 1988. Since its introduction, it has become one of the most widely utilized UVA filters globally due to its ability to absorb long-wave radiation that penetrates deeper into the dermis (the thick layer of living tissue below the epidermis). By absorbing these rays, it helps prevent photoaging (premature skin aging caused by light), solar elastosis (accumulation of abnormal elastic tissue), and reduces the risk of skin malignancies (cancers) associated with chronic UVA exposure. Because it is an oil-soluble ingredient, it is frequently formulated into creams, lotions, and sun-protective sprays.
At the molecular level, Butyl Methoxydibenzoylmethane functions through a sophisticated process of energy absorption and dissipation. It is an organic filter, meaning it does not reflect light like physical blocks (e.g., Zinc Oxide); instead, it absorbs UV photons. When UVA radiation hits the skin, the Butyl Methoxydibenzoylmethane molecule undergoes a structural transition. It exists in a state of keto-enol tautomerism (a chemical equilibrium between a ketone and an alcohol).
In its 'enol' form, the molecule is highly efficient at absorbing UV energy. Once it absorbs a photon, it enters an 'excited' state. To return to its stable 'ground' state, it must release this energy. It typically does this by converting the UV energy into harmless infrared radiation (heat), which is then dissipated from the skin's surface. This process prevents the UV radiation from reaching the DNA of skin cells, where it could otherwise cause oxidative stress, generate free radicals (unstable molecules), and lead to mutations or collagen breakdown.
A critical clinical characteristic of Butyl Methoxydibenzoylmethane is its photolability. When exposed to sunlight in isolation, the molecule can lose up to 50% to 90% of its filtering capacity within one hour. To counteract this, pharmaceutical chemists almost always co-formulate it with 'photostabilizers' such as Octocrylene, Bemotrizinol, or Diethylhexyl Syringylidenemalonate. These stabilizers help the molecule return to its ground state more efficiently without breaking down, ensuring sustained protection during sun exposure.
Historically, topical sunscreens were thought to remain entirely on the stratum corneum (the outermost layer of the skin). However, recent clinical pharmacology studies have updated our understanding of the systemic absorption of Butyl Methoxydibenzoylmethane.
Butyl Methoxydibenzoylmethane is indicated for the following uses:
Butyl Methoxydibenzoylmethane is never used as a standalone drug; it is always an active ingredient in topical formulations, including:
> Important: Only your healthcare provider or a board-certified dermatologist can determine if Butyl Methoxydibenzoylmethane is right for your specific skin condition or if you require alternative protection strategies.
For Butyl Methoxydibenzoylmethane to provide the labeled level of protection (SPF), it must be applied at a specific density. The standard clinical recommendation is 2 milligrams of product per square centimeter (2 mg/cm²) of skin.
There are currently no specific dosage adjustments required for patients with kidney disease, as systemic absorption is minimal. However, patients with end-stage renal disease (ESRD) who may have 'uremic pruritus' (itchy skin) should use fragrance-free formulations to avoid further irritation.
No dosage adjustments are necessary for patients with liver impairment. While the liver is involved in metabolizing any absorbed fraction, the levels are typically too low to necessitate a change in topical application.
Older adults often have 'atrophic skin' (thinned skin). While no dose reduction is needed, elderly patients should be monitored for signs of irritant contact dermatitis, as their skin barrier may be more easily compromised.
If you forget to apply Butyl Methoxydibenzoylmethane before sun exposure, apply it as soon as you remember. However, be aware that the skin may have already sustained UV damage. If you are already outdoors and realize you missed a dose, seek shade immediately until the product has been applied and had time to set.
> Important: Follow your healthcare provider's dosing instructions and the directions on the OTC 'Drug Facts' label. Do not adjust your application frequency without medical guidance, especially if you have a history of skin cancer.
Butyl Methoxydibenzoylmethane is generally well-tolerated, but because it is a chemical filter, some users may experience localized skin reactions. Common effects include:
> Warning: Stop using products containing Butyl Methoxydibenzoylmethane and call your doctor immediately if you experience any of the following:
There has been ongoing scientific debate regarding the long-term effects of systemic absorption of Butyl Methoxydibenzoylmethane.
There are currently no FDA Black Box Warnings for Butyl Methoxydibenzoylmethane. It is categorized as GRASE (Generally Recognized As Safe and Effective) for its intended use as a topical sunscreen agent.
Report any unusual symptoms, persistent rashes, or severe skin changes to your healthcare provider. If you suspect a photoallergy, a dermatologist can perform 'photopatch testing' to confirm the diagnosis.
Butyl Methoxydibenzoylmethane is for external use only. It is not meant to be ingested or applied to mucosal membranes (inside the mouth, nose, or genitals). While it is highly effective at blocking UVA rays, it does not provide 100% protection. Users should always combine sunscreen use with other protective measures, such as wearing hats, sunglasses, and seeking shade during peak UV hours (10 AM to 4 PM).
No FDA black box warnings for Butyl Methoxydibenzoylmethane. It has a long history of safe use in the global consumer market.
There are no routine lab tests (like blood counts or liver panels) required for the standard use of Butyl Methoxydibenzoylmethane. However, patients using it for medical reasons (e.g., preventing flares of Lupus) should have regular skin examinations by a dermatologist to monitor for:
Butyl Methoxydibenzoylmethane does not cause drowsiness or cognitive impairment. It has no known effect on the ability to drive or operate heavy machinery.
There is no known interaction between the topical use of Butyl Methoxydibenzoylmethane and the consumption of alcohol. However, alcohol consumption can cause vasodilation (widening of blood vessels), which may make the skin feel warmer or more sensitive to the 'stinging' sensation sometimes associated with sunscreens.
If you develop a persistent rash, swelling, or itching, you should discontinue use immediately. There is no 'withdrawal' syndrome associated with stopping Butyl Methoxydibenzoylmethane. However, stopping use will immediately leave your skin vulnerable to UVA radiation, so an alternative protection method (like a physical blocker or UV-protective clothing) must be substituted.
> Important: Discuss all your medical conditions, especially history of skin cancer or eczema, with your healthcare provider before starting a new regimen containing Butyl Methoxydibenzoylmethane.
There are no absolute drug-drug contraindications for topical Butyl Methoxydibenzoylmethane. However, certain chemical combinations in the same bottle are avoided by manufacturers:
There are no known food interactions with topically applied Butyl Methoxydibenzoylmethane. It does not interact with grapefruit, dairy, or caffeine.
For each interaction, the management strategy is typically 'staggered application'—leaving time between the application of different topical products.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, even if they are 'natural' or over-the-counter.
Butyl Methoxydibenzoylmethane must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis by a physician:
There is a potential for cross-sensitivity between Butyl Methoxydibenzoylmethane and certain fragrances or chemical preservatives. Specifically, individuals allergic to Isolates of Balsam of Peru or certain dibenzoylmethane-based dyes may also react to this sunscreen agent.
> Important: Your healthcare provider will evaluate your complete medical history and skin type before recommending a specific sunscreen formulation.
FDA Pregnancy Category: Not formally assigned (as it is an OTC topical), but generally considered safe for use during pregnancy.
No dosage adjustment is required for patients with renal impairment. The amount absorbed systemically is negligible compared to the body's clearance capacity, even in those with reduced GFR (Glomerular Filtration Rate).
No dosage adjustment is required. Even in patients with Child-Pugh Class C cirrhosis, the topical application of Butyl Methoxydibenzoylmethane does not pose a known risk of hepatotoxicity.
> Important: Special populations, particularly pregnant women and those with chronic skin conditions, require individualized medical assessment to choose the safest photoprotection strategy.
Butyl Methoxydibenzoylmethane is a UVA filter. Its molecular structure contains a conjugated system that allows it to absorb high-energy UV photons. Specifically, it targets the 320–400 nm range. When it absorbs light, it undergoes an intramolecular hydrogen transfer, moving from an 'enol' tautomer to a 'keto' tautomer. This process dissipates the energy as heat. Because it covers the UVA-I range (340–400 nm), it is one of the few organic molecules capable of protecting against the wavelengths that penetrate most deeply into the skin and cause long-term structural damage.
| Parameter | Value |
|---|---|
| Bioavailability | <1-2% (Topical) |
| Protein Binding | Not definitively characterized in humans |
| Half-life | 33–55 hours (Systemic fraction) |
| Tmax | 24 hours (Time to peak plasma level after repeated application) |
| Metabolism | Likely Hepatic (Glucuronidation) |
| Excretion | Primarily Renal |
Butyl Methoxydibenzoylmethane is classified as an Organic UVA Filter. It is often grouped with other chemical sunscreens like Oxybenzone and Octisalate, though its specific UVA-I coverage distinguishes it from most other members of the class.
Medications containing this ingredient
Calliel Glow Primer Broad Spectrum Spf 50 Sunscreen
St Moriz Suncare Spf 50 Sunscreen Body
Skin1004 Madagascar Centella Hyalu-cica Water-fit Sun Serum Uv
Advanced Day Ultimate Protect Sunscreen Spf 50
Jer Moisturizing And Translucent Sunscreen
Spf30 Unseen Sunscreen
Birdie Glow Sparklelotion Spf 15
Inblair Moisturizer Spf 15
Icd Moisture Layer Sunscreen
Les Coja Organic Spf 30
Inblair Elevate Spf15 Moisturizer
Calliel Unseen Sunscreen Spf 50
Common questions about Butyl Methoxydibenzoylmethane
Butyl Methoxydibenzoylmethane, also known as Avobenzone, is primarily used as an active ingredient in sunscreens to provide broad-spectrum protection against Ultraviolet A (UVA) rays. These rays are responsible for premature skin aging, wrinkles, and long-term DNA damage that can lead to skin cancer. Unlike many other sunscreen ingredients that only block UVB rays (which cause sunburn), this compound is one of the few that covers the entire UVA spectrum. It is found in daily moisturizers, sunscreens, and cosmetics to help prevent photoaging and reduce the risk of skin malignancies. Healthcare providers often recommend products containing this ingredient for patients with light-sensitive conditions like lupus.
The most common side effects are localized skin reactions, such as mild stinging, burning, or itching immediately after application. Some users may develop a red rash known as contact dermatitis, which is often a reaction to the cream base or other additives in the sunscreen. If the product gets into the eyes, it can cause significant irritation and tearing. In rare cases, some individuals may experience a 'photoallergy,' where a rash only appears after the skin with the sunscreen is exposed to sunlight. Most side effects are minor and resolve quickly once the product is washed off the skin.
Yes, there is no known interaction between the topical application of Butyl Methoxydibenzoylmethane and the consumption of alcohol. Because the ingredient is applied to the skin and very little enters the bloodstream, it does not interfere with how the body processes alcohol. However, alcohol can cause the skin's blood vessels to dilate, which might make your skin feel more sensitive or prone to redness when applying topical products. Additionally, excessive alcohol consumption can lead to dehydration, which may worsen the skin dryness sometimes caused by alcohol-based sunscreen sprays. Always use caution when applying flammable sunscreen sprays near someone who is smoking or near an open flame.
Butyl Methoxydibenzoylmethane is generally considered safe for use during pregnancy, and most dermatologists recommend its use to prevent melasma (dark skin patches) which often occurs due to hormonal changes. While recent studies have shown that small amounts of the chemical can be absorbed into the bloodstream, there is currently no evidence that this poses a risk to the developing fetus. The American College of Obstetricians and Gynecologists emphasizes the importance of sun protection during pregnancy to prevent skin damage. If you have concerns about chemical absorption, you can discuss using 'physical' or 'mineral' sunscreens containing zinc oxide with your doctor. Always consult your healthcare provider before starting new skincare routines during pregnancy.
Butyl Methoxydibenzoylmethane begins to work as soon as it is applied to the skin, but it requires about 15 to 20 minutes to form a stable, protective film. This 'setting' time is crucial because it ensures the product has bonded with the outer layer of the skin and won't be easily wiped or sweated off. If you go directly into intense sunlight or water immediately after application, the protection may be uneven or significantly reduced. For the best results, healthcare providers recommend applying the product indoors before you head outside. This allows the active ingredients to provide the full Sun Protection Factor (SPF) and UVA protection labeled on the bottle.
Yes, you can stop using products containing Butyl Methoxydibenzoylmethane at any time without experiencing withdrawal symptoms or physical side effects. Since it is a topical agent and not a systemic medication, your body does not become dependent on it. However, the moment you stop applying it, your skin loses its protection against harmful UVA radiation. If you have been using it to manage a medical condition like photosensitivity or to prevent skin cancer, you should immediately substitute it with another form of protection, such as a different sunscreen or UV-protective clothing. Consult your dermatologist if you are stopping use due to a suspected allergic reaction.
If you forget to apply Butyl Methoxydibenzoylmethane before going into the sun, apply it as soon as you realize the omission. While the skin may have already received some UV damage, applying it late is still better than not applying it at all for the remainder of your time outdoors. If you are already in the sun, try to find shade for 15 minutes after the late application to allow the film to set properly. Remember that sun damage is cumulative, so missing doses frequently can increase your long-term risk of skin aging and cancer. It is helpful to keep a travel-sized bottle in your bag or car to avoid missing applications when away from home.
No, Butyl Methoxydibenzoylmethane does not cause weight gain. It is a topical sunscreen ingredient that stays primarily on the surface of the skin, and the tiny amount that may be absorbed into the bloodstream is not enough to affect your metabolism, appetite, or fat storage. Unlike certain systemic medications like steroids or some antidepressants, topical UV filters have no mechanism for altering body weight. Any changes in weight you experience while using sunscreens are likely due to other factors such as diet, exercise, or unrelated medical conditions. If you have concerns about unexpected weight changes, you should discuss them with your primary care physician.
Butyl Methoxydibenzoylmethane is generally safe to use alongside most oral medications. However, it can interact with other topical products applied to the same area of skin. For example, using it with insect repellents containing DEET can reduce the effectiveness of the sunscreen. It is also important to be cautious if you are using topical acne treatments like benzoyl peroxide or retinoids, as these can make your skin more sensitive to irritation from the sunscreen. To avoid issues, it is usually recommended to apply medicated creams first, wait for them to absorb fully, and then apply the sunscreen. Always inform your doctor about all topical and oral treatments you are using.
Butyl Methoxydibenzoylmethane is the 'generic' or chemical name for the ingredient often marketed under the trade name Avobenzone. It is not a prescription drug, so it doesn't have a 'generic version' in the traditional sense of a pill. Instead, it is an active ingredient found in hundreds of different over-the-counter sunscreen brands, ranging from expensive luxury products to affordable store-brand versions. Regardless of the brand name or price, the FDA regulates the concentration of Butyl Methoxydibenzoylmethane to ensure it is safe and effective. You can check the 'Active Ingredients' section of the Drug Facts label on any sunscreen bottle to see if it contains this specific compound.